Furthermore, treatment with GIP/ICG@P/R8 NPs effectively improves systemic metabolic profiles, including a 9.23% reduction in body weight after 14 days, enhanced insulin sensitivity, and amelioration of fatty liver. This evidence concerns the gene INS and fatty liver disease.